Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious condition where jawbone tissue is exposed and does not heal, often linked to certain bone-modifying or antiangiogenic drugs.
The Detroit News on MSN: Dr. Roach: A tooth extraction presents a risk for osteonecrosis of the jaw
Dr. Roach: A tooth extraction presents a risk for osteonecrosis of the jaw
The Daily Courier: To Your Good Health: A tooth extraction presents a risk for osteonecrosis of the jaw
To Your Good Health: A tooth extraction presents a risk for osteonecrosis of the jaw
MSN: Osteonecrosis of the Jaw: A Rare Side Effect of Osteoporosis Therapy
Some of the most commonly used medications for osteoporosis can lead to osteonecrosis of the jaw (ONJ), a rare but serious side effect. "Inflammation and infection [in the mouth] plus a potent ...
Philadelphia, PA - A review of jaw osteonecrosis as a recently described adverse effect of bisphosphonate therapy in the issue of the Annals of Internal Medicine concludes that most cases ...
MedPage Today: Osteonecrosis of the Jaw: A Rare Side Effect of Osteoporosis Therapy
Renal & Urology News: Oral Corticosteroids and Tumor-Targeting Drugs Drive Osteonecrosis of the Jaw in CKD
The use of antiresorptive drugs for tumor-related disorders and oral, but not injectable, corticosteroids were associated with an increased risk for osteonecrosis of the jaw among patients with ...
Oral Corticosteroids and Tumor-Targeting Drugs Drive Osteonecrosis of the Jaw in CKD
Osteonecrosis of the jaw (ONJ) is a serious complication for physicians prescribing bone resorption inhibitors to patients with osteoporosis. A session at the recent French Congress of Rheumatology ...